Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Felcoon Jun 15, 2017 5:37pm

282 Views

Post# 26368453

Barcodewhiz

Hi Barcodewhiz,

Any thoughts on this? You seemed pretty confident management wouldn't go down this road in your most recent postings.

I'm very disappointed management took such an aggressive approach with their various initiatives putting this much pressure on cash resourses. Sub $1.70 tomorrow.

Anyway, if you're around, it would be nice to read your take.

Thanks,
Felco

Bullboard Posts

NTG Clarity Networks' growth story continues with $22M contract